Users' perspectives on medical abortion in Finland.
The objective of this study was to determine the reasons for choosing the medical instead of surgical method for the termination of early pregnancy, and to evaluate the experience and the level of satisfaction with the medical method among women in Helsinki who participated in a multinational efficacy study of medical abortion. The study respondents consisted of 123 women with less than 9 weeks gestation, undergoing medical abortion with mifepristone 200 mg orally followed 36 h to 48 h later by misoprostol 0.8 mg orally or vaginally. By using structured questionnaires, the reasons for choosing the medical method were assessed before the abortion, whereas the experience of medical abortion was evaluated at follow-up visits 2 weeks and 6 weeks later. The three most important reasons for choosing medical abortion instead of surgical abortion were 'avoidance of surgery,' 'avoidance of general anesthesia,' and 'the method being more natural.' At the 6-week evaluation, most women (92%) were satisfied or highly satisfied with the method, and 103 (88%) women said that the method met their expectations. The majority of all women, 105 (89%), would opt for the same method in the future should the need arise, and 102 (88%) patients would recommend the medical method to a friend. The length of pregnancy had an effect on acceptability; the shorter the gestational age, the more acceptable the medical abortion. Medical abortion was perceived as an acceptable method for termination of early pregnancy among the Finnish women studied.
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. helena.honkanen@hus.fi
Helena
H
Honkanen
Helena
H
von Hertzen
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000523:psychology* / Q000706:statistics & numerical data; D000328:Adult; D001294:Attitude to Health; D005260:Female; D005387:Finland; D005865:Gestational Age; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage; D016595:Misoprostol / Q000008:administration & dosage*; D017060:Patient Satisfaction; D011247:Pregnancy
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol; D015735:Mifepristone